Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ETV5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OPTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNASE1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBOAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1H1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1841 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0391 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NORAD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASET2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EFCAB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM161A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIOBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on